Restrictive REMS Is Least Favored Path For Opioid Prescriber Education
Executive Summary
FDA advisory committee's preferred approaches – linking mandatory training to DEA registration or state medical board licensing – are outside agency's existing regulatory authority.
You may also be interested in...
US FDA Needs ‘More Streamlined’ REMS Enforcement Authority, Inspector General Says
Additional power would allow the agency to punish 'simple' REMS violations and improve administration of risk management programs, according to a new report looking at FDA's oversight of opioids.
Opioids: Senate Wants Mandatory Prescriber Training; Can FDA Make It Work?
Appropriations bill report includes language stating that it is 'imperative' the agency take all steps necessary to require opioid prescriber training.
FDA Expanding Opioid REMS To Immediate Release Formulations
Commissioner Gottlieb tells opioid scientific workshop that updated REMS will also require training to be available to nurses and pharmacists; agency beginning new study on prescriber perceptions.